Skip Navigation
Skip to contents

Cancer Res Treat : Cancer Research and Treatment

Search
Advanced Search
OPEN ACCESS
mobile search button mobile menu button

Articles

Page Path
HOME > Cancer Res Treat > Volume 37(2); 2005 > Article
Original Article Clinicopathological Analysis of Borrmann Type IV Gastric Cancer
Jeong Hwan Yook, M.D., Sung Tae Oh, M.D., Byung Sik Kim, M.D.
Cancer Research and Treatment : Official Journal of Korean Cancer Association 2005;37(2):87-91.
DOI: https://doi.org/10.4143/crt.2005.37.2.87
Published online: April 30, 2005

Department of Surgery, Ulsan University College of Medicine, Seoul, Korea.

Correspondence: Jeong Hwan Yook, Department of Surgery, Ulsan University College of Medicine, and Asan Medical Center, 388-1 Pungnap-2dong, Songpa-gu, Seoul 138-736, Korea. (Tel) 82-2-3010-3496, (Fax) 82-2-474-9027, jhyook@amc.seoul.kr
• Received: January 13, 2005   • Accepted: April 14, 2005

Copyright © 2005 Korean Cancer Association

  • 11,350 Views
  • 104 Download
  • 26 Crossref
prev next
Full Article

Download PDF Download PDF

  • Purpose
    Borrmann type IV gastric cancer is often diagnosed only at an advanced stage, resulting in a prognosis poor. We performed a retrospective study of the clinical characteristics of Borrmann type IV gastric cancer and the prognostic factors affecting the survival rate in such patients.
  • Materials and Methods
    Of 4,063 patients with all gastric cancers, 370 (9%) with Borrmann type IV gastric cancer were analyzed.
  • Results
    The clinical characteristics of these patients included a higher incidence rate in young females, and higher rates of serosa exposure, metastasis to lymph nodes and early peritoneal dissemination. Of patients presenting with peritoneal seeding, those resected had a higher survival rate than those that were not. A univariate analysis showed that the prognostic factors affecting the survival rate following a curative resection were the location, occupied area and depth of the primary tumor, as well as the presence of lymph node metastasis and the tumor stage. A multivariate analysis indicated that the tumor location and stage were significant independent prognostic factors after a curative resection for Borrmann type IV gastric cancer.
  • Conclusion
    In conclusion, the early diagnosis and treatment of patients with Borrmann type IV gastric cancer are essential for the better survival of these patients. Even in patients with advanced tumors, a noncurative palliative resection may improve the prognosis.
  • Key words: Borrmann type IV, Stomach neoplasms
Advances in diagnostic techniques and treatment methods for gastric cancer have improved overall treatment outcomes. The early diagnosis of Borrmann type IV gastric cancer is difficult, as no ulceration or elevation appears on the mucosal surface in the early phases of the tumor. These tumors are; therefore, often diagnosed at an advanced stage, making the prognosis very poor (1,2). Peritoneal dissemination is a major problem and the leading cause of death in patients with Borrmann type IV gastric cancer (1). The recurrence rate of a peritoneal dissemination after a resection is very high, making its prevention necessary for improved survival (2,3) Although many surgeons have made efforts to prevent peritoneal recurrence, these have not been successful. To date, there is no effective treatment for a peritoneal dissemination after a resection for Borrmann type IV gastric cancer. To improve the treatment results for Borrmann type IV gastric cancer, detailed clarification of the prognostic factors is important. Therefore, we retrospectively analyzed the clinicopathological characteristics and prognostic factors affecting the survival rate of patients with Borrmann type IV gastric cancer.
The medical records of 370 patients with Borrmann type IV gastric cancer, who underwent exploratory surgery at the Department of Surgery, Asan Medical Center, between 1989 and 1997, were retrospectively analyzed. These patients constituted 9% of the 4,063 patients with gastric cancers who underwent exploratory surgery during the same period. The age, gender, histological findings, and the location and depth of tumor invasion, lymph node metastasis, tumor stage and the clinical course for recurrence and prognosis were retrospectively examined from the medical chart and data of the National Statistical Office. No patient was lost during the median 27 months follow up period (ranging from 1 to 109 months). One hundred and eighty two patients underwent resection for the primary tumor, and when the tumor involved an adjacent organ, that organ was also resected. The histological type, and location and depth of tumor invasion, the extent of lymph node metastasis and the stage of the primary tumors were determined according to the classification of gastric carcinomas of the Japanese Gastric Cancer Association (4).
Survival curves were determined using the Kaplan-Meier method. An analysis of the difference between the survival rates was performed using the log-rank test. The multivariate analysis was performed using Cox's proportional hazard model. Differences between groups were considered statistically significant at p<0.05. The SPSS statistical software was used for the above analysis.
The average age of the 370 patients (203 males, 167 females) who underwent a resection for Borrmann type IV gastric cancer was 53 years, ranging from 21 to 81 years. Although the overall male to female ratio was 1.23 to 1, this was reversed in younger patients (Fig. 1). Tumors were located with similar frequency in the antral and body regions, with 156 tumors (42.2%) involving the whole stomach. One hundred and thirteen tumors (30.5%) were localized to only one region, while the remainder occupied two regions, either the antral and body regions or the body and cardiac regions. Serosa-exposure was observed in 322 patients (87%), while lymph node metastasis was confirmed in 223 (60.3%). Although peritoneal dissemination was detected in 141 patients (38.1%) at the time of surgery, hepatic metastasis was observed in only 14 (3.9%, Table 1). A curative resection was performed on 182 patients (49.1%). The overall 5 year survival rate of patients with Borrmann type IV gastric cancer was 24.3%; whereas, for patients either receiving a curative resection or not resected were 38.4 and 4.5%, respectively (Fig. 2). The univariate analysis showed the prognostic factors affecting the survival rate after a curative resection were the location (p=0.014), occupied region (p<0.001) and depth (p<0.001) of the primary tumor, as well as the presence of lymph node metastasis (p=0.04) and the tumor stage (p<0.001, Table 2). The multivariate analysis indicated that the tumor location and stage were significant independent prognostic factors after a curative resection for Borrmann type IV gastric cancer (Table 3). Of the 121 patients who experienced a recurrence after a curative resection, peritoneal dissemination was the main site of the recurrence in 90 (74.3%). The most frequent site of hematogenous metastasis was the bone marrow (Table 4). Of the patients in whom peritoneal dissemination was observed at the time of surgery, the survival rate for those who were resected was longer than for those who were not (p<0.05, Fig. 3). Among the resected patients with peritoneal dissemination, the prognosis was the same for those with both positive and negative resection margins (p=0.84, Fig. 4).
The clinical characteristics of Borrmann type IV gastric cancer include a high rate of incidence in young females (1,2,5), delayed diagnosis and detection at an advanced stage (1,2,5~7), peritoneal dissemination at the first operation (1), many peritoneal recurrences after a curative resection (1~3), low hepatic metastasis (1,2) and a low curative resection rate (2). Difficulties in treating this type of tumor may be due to both these specific characteristics and the late diagnosis. Thus, patients with Borrmann type IV gastric cancer have a poorer prognosis than those with other types of gastric cancer.
We found that 9% of patients with gastric cancers had Borrmann type IV gastric cancer, an incidence rate similar to that observed in other studies (1,5,8,9). We also found that the mean age of patients with Borrmann type IV gastric cancer was similar to that of all gastric cancer patients in Korea (8). In contrast, we observed a lower male to female ratio in Borrmann type IV gastric cancer patients than previously reported of all gastric cancer patients (8).
It has been hypothesized that patients with gastric linitis plastica who have liver metastasis, peritoneal dissemination and serosal involvement, or local extension of the tumor, would not benefit from a total gastrectomy, making only 20% of these patients candidates for palliative surgery (10). For the remainder, it has been suggested that alternative forms of treatment, other than surgery, including chemotherapy and/or radiation therapy, should be selected (10). It has been reported; however, that very extensive surgery, consisting of left upper abdominal exenteration plus the Appleby's method, improved the survival of patients with scirrhous cancer (11). The prognosis of patients with a scirrhous carcinoma of the stomach is mainly determined by the depth of penetration and curability, making early detection crucial for better survival (9,10,12). As the stage of tumor was found to be an independent prognostic factor in our multivariate analysis, the diagnosis at an early stage is very important in lengthening the survival time. However, only 6.7% of the patients with Borrmann type IV gastric cancer initially present with a stage II tumor (13). In our study, 49.1% of patients were treated with a curative resection, with the 5 year survival rate in this group being 38.4%, which was longer than that observed in other studies (2,14). This may have been due to the higher incidence of earlier stage patients in our study, providing further evidence that early diagnosis and treatment are essential to improve the survival of patients with Borrmann type IV gastric cancer.
It has been reported that a palliative gastrectomy may improve the prognosis of selected patients with peritoneal dissemination, but may be ineffective in patients with synchronous liver metastasis (15). It has been suggested that surgery should not be confined to a gastrectomy, but should also include a lymphadenectomy (16). In our patients with peritoneal dissemination, the median survival time of the resected group (11 months) was found to be significantly longer than that of the non-resected group (7 months). Although our study was not a randomized, controlled trial, the results suggest that a non- curative resection may lengthen the survival time in selected patients with peritoneal disseminations. Since patients with negative and positive resection margins of the gastrectomy of the peritoneal disseminations had similar survival rates, it is not necessary to obtain a negative safety margin at the time of a palliative non-curative resection. However, to determine the effect of a noncurative resection, a randomized trial may be necessary. Finally, in our study, 90 (64%) patients with peritoneal disseminations could not undergo a curative or palliative resection. Considering this undesirable result, it is very important to advance the diagnostic tools for peritoneal disseminations, such as laparoscopic staging work-up.
Borrmann type IV gastric cancer typically presents as an advanced stage tumor, with serosa-exposure and metastasis to the lymph nodes, as well as peritoneal dissemination. The early diagnosis and treatment are essential for better survival of these patients. Although these tumors are usually at an advanced stage, with surgery usually being palliative, a noncurative palliative resection may improve the prognosis.
  • 1. Kitamura K, Beppu R, Anai H, Ikejiri K, Yakabe S, Sugimachi K, et al. Clinicopathologic study of patients with Borrmann type IV gastric carcinoma. J Surg Oncol. 1995;58:112–117. PMID: 7844980ArticlePubMed
  • 2. Maehara Y, Moriguchi S, Orita H, Kakeji Y, Haraguchi M, Korenaga D, et al. Lower survival rate for patients with carcinoma of the stomach of Borrmann type IV after gastric section. Surg Gynecol Obstet. 1992;175:13–16. PMID: 1621194PubMed
  • 3. Moriguchi S, Maehara Y, Korenaga D, Sugimachi K, Nose Y. Risk factors which predict pattern of recurrence after curative surgery for patients with advanced gastric cancer. Surg Oncol. 1992;1:341–346. PMID: 1341269ArticlePubMed
  • 4. Japanese Research Society for Gastric CancerJapanese classification of gastric carcinoma. 1998. 2nd English ed. Tokyo: Kanehara.
  • 5. Hirose S, Honjou H, Nakagawa H, Nishimura K, Kuroda Y, Tsuji M, et al. Scirrhous carcinoma of the stomach: a clinical and pathological study of 106 surgical cases. Gastroenterol Jpn. 1989;24:481–487. PMID: 2553523ArticlePubMed
  • 6. Nagayo T, Yokoyama H. Scirrhous carcinoma occurring in the corpus (body) of the stomach. Acta Pathol Jpn. 1974;24:797–814. PMID: 4376327ArticlePubMed
  • 7. Sugano H, Nakamura K, Kato Y. Pathological studies of human gastric cancer. Acta Pathol Jpn. 1982;32(suppl 2):329–347. PMID: 6765003PubMed
  • 8. Kim JP, Lee JH, Kim SJ, Yu HJ, Yang HK. Clinicopathologic characteristics and prognostic factors in 10,783 patients with gastric cancer. Gastric Cancer. 1998;1:125–133. PMID: 11957056ArticlePubMed
  • 9. Kinugasa S, Abe S, Tachibana M, Yoshimura H, Monden N, Dhar DK, et al. Surgically curable and incurable scirrhous carcinomas of the stomach. J Surg Oncol. 1997;65:194–200. PMID: 9236929ArticlePubMed
  • 10. Aranha GV, Georgen R. Gastric linitis plastica is not a surgical disease. Surgery. 1989;106:758–762. PMID: 2552599PubMed
  • 11. Furukawa H, Hiratsuka M, Iwanaga T, Imaoka S, Ishikawa O, Kabuto T, et al. Extended surgery-left upper abdominal exenteration plus Appleby's method-for type 4 gastric carcinoma. Ann Surg Oncol. 1997;4:209–214. PMID: 9142381ArticlePubMed
  • 12. Otsuji E, Yamaguchi T, Sawai K, Sakakura C, Okamoto K, Takahashi T. Regional lymph node metastasis as a predictor of peritoneal carcinomatosis in patients with Borrmann type IV gastric carcinoma. Am J Gastroenterol. 1999;4:434–437. PMID: 10022642Article
  • 13. Furukawa H, Hiratsuka M, Iwanaga T. A rational technique for surgical operation on Borrmann type 4 gastric carcinoma: left upper abdominal evisceration plus Appleby's method. Br J Surg. 1988;75:116–119. PMID: 3349295ArticlePubMed
  • 14. Arveux P, Faivre J, Boutron MC, Piard F, Dusserre-Guion L, Monnet E, et al. Prognosis of gastric carcinoma after curative surgery. A population-based study using multivariate crude and relative survival analysis. Dig Dis Sci. 1992;37:757–763. PMID: 1563320ArticlePubMed
  • 15. Hanazaki K, Sodeyama H, Mochizuki Y, Igarashi J, Yokoyama S, Sode Y, et al. Palliative gastrectomy for advanced gastric cancer. Hepatogastroenterology. 2001;48:285–289. PMID: 11268986PubMed
  • 16. Maeta M, Sugesawa A, Ikeguchi M, Tsujitani S, Yamashiro H, Shibata S, et al. Does the extent of lymph node dissection affect the postoperative survival of patients with gastric cancer and disseminating peritoneal metastases? Surg Today. 1994;24:40–43. PMID: 7519911ArticlePubMed
Fig. 1
Age and sex distribution.
crt-37-87-g001.jpg
Fig. 2
Comparison of survival rate between curative resection and other group (p<0.05).
crt-37-87-g002.jpg
Fig. 3
Comparison of survival rate between resection and nonresection group in peritoneal seeding patients (p<0.05).
crt-37-87-g003.jpg
Fig. 4
Comparison of effect to survival rate between negative and positive resection margin of gastrectomy in peritoneal seeding patients (p=0.84).
crt-37-87-g004.jpg
Table 1
Clinical characteristics of Borrmann type IV gastric cancers (n=370)
crt-37-87-i001.jpg

*(+) means positive microscopic cancer cell in tissue.

Table 2
Comparison of survival rates according to clinical factors in curative resection (n=182)
crt-37-87-i002.jpg

*L=lower 1/3, M=middle 1/3, U=upper 1/3; †1 region=lower, middle, upper area, 2 regions=lower 1/3 + middle 1/3 or middle 1/3+ upper 1/3.

Table 3
Multivariate analysis of prognostic factors after curative resection (n=182)
crt-37-87-i003.jpg

*Confidence interval.

Table 4
Site of recurrences after curative resection (n=121)
crt-37-87-i004.jpg

Figure & Data

REFERENCES

    Citations

    Citations to this article as recorded by  
    • Borrmann Type IV Gastric Cancer: Computed Tomography Features and Corresponding Pathological Findings
      Changfeng Ji, Yi Ma, Zhong Zheng, Song Liu, Zhengyang Zhou
      Journal of Computer Assisted Tomography.2024; 48(2): 200.     CrossRef
    • Clinicopathological and prognostic features of Borrmann type IV gastric cancer versus other Borrmann types: A unique role of signet ring cell carcinoma
      Chengcai Liang, Yao Liang, Biyi Ou, Lei Yuan, Shuqiang Yuan
      Saudi Journal of Gastroenterology.2023; 29(4): 240.     CrossRef
    • PN3b as an independent risk factor for poor prognosis and peritoneal recurrence in Borrmann type IV gastric cancer: A retrospective cohort study
      Yiran Chen, Yanyan Chen, Liping Wen, Laizhen Tou, Haiyong Wang, Lisong Teng
      Frontiers in Surgery.2022;[Epub]     CrossRef
    • Comparative Outcomes of Laparoscopic Gastrectomy and Open Gastrectomy for Scirrhous Gastric Cancer: A Multicenter Retrospective Cohort Study
      Yusuke Fujita, Tatsuto Nishigori, Yoshio Kadokawa, Atsushi Itami, Masato Kondo, Hisahiro Hosogi, Seiichiro Kanaya, Hironori Kawada, Hiroaki Hata, Michihiro Yamamoto, Yousuke Kinjo, Eiji Tanaka, Dai Manaka, Seiji Satoh, Hiroshi Okabe, Shigeru Tsunoda, Masa
      Annals of Surgery Open.2021; 2(2): e063.     CrossRef
    • Are Borrmann’s Types of Advanced Gastric Cancer Distinct Clinicopathological and Molecular Entities? A Western Study
      Cristina Díaz del Arco, Luis Ortega Medina, Lourdes Estrada Muñoz, Elena Molina Roldán, M. Ángeles Cerón Nieto, Soledad García Gómez de las Heras, M. Jesús Fernández Aceñero
      Cancers.2021; 13(12): 3081.     CrossRef
    • Borrmann Type IV Gastric Cancer: Focus on the Role of Gastrectomy
      Chengcai Liang, Guoming Chen, Baiwei Zhao, Haibo Qiu, Wei Li, Xiaowei Sun, Zhiwei Zhou, Yingbo Chen
      Journal of Gastrointestinal Surgery.2020; 24(5): 1026.     CrossRef
    • Subtotal gastrectomy combined with chemotherapy: An effective therapy for patients with circumscribed Borrmann type IV gastric cancer
      Hai-Bo Huang, Zi-Ming Gao, An-Qi Sun, Wei-Tian Liang, Kai Li
      World Journal of Gastrointestinal Oncology.2020; 12(11): 1325.     CrossRef
    • Role of Cancer-Associated Fibroblast in Gastric Cancer Progression and Resistance to Treatments
      In-Hye Ham, Dagyeong Lee, Hoon Hur
      Journal of Oncology.2019; 2019: 1.     CrossRef
    • Endoscopic ultrasound‑guided fine‑needle aspiration biopsy for diagnosis of gastric linitis plastica with negative malignant endoscopy biopsies
      Yingjian Ye, Shiyun Tan
      Oncology Letters.2018;[Epub]     CrossRef
    • Muscle RAS oncogene homolog (MRAS) recurrent mutation in Borrmann type IV gastric cancer
      Makiko Yasumoto, Etsuko Sakamoto, Sachiko Ogasawara, Taro Isobe, Junya Kizaki, Akiko Sumi, Hironori Kusano, Jun Akiba, Takuji Torimura, Yoshito Akagi, Hiraku Itadani, Tsutomu Kobayashi, Shinichi Hasako, Masafumi Kumazaki, Shinji Mizuarai, Shinji Oie, Hiro
      Cancer Medicine.2017; 6(1): 235.     CrossRef
    • Endoscopic ultrasound-guided cutting of holes and deep biopsy for diagnosis of gastric infiltrative tumors and gastrointestinal submucosal tumors using a novel vertical diathermic loop
      Yu-Mei Liu, Xiu-Jiang Yang
      World Journal of Gastroenterology.2017; 23(15): 2795.     CrossRef
    • Clinicopathologic characteristics and prognosis of Borrmann type IV gastric cancer: a meta-analysis
      Yifan Luo, Peng Gao, Yongxi Song, Jingxu Sun, Xuanzhang Huang, Junhua Zhao, Bin Ma, Yuan Li, Zhenning Wang
      World Journal of Surgical Oncology.2016;[Epub]     CrossRef
    • Borrmann type IV gastric cancer should be classified as pT4b disease
      Jin-yu Huang, Zhen-ning Wang, Chun-yang Lu, Zhi-feng Miao, Zhi Zhu, Yong-xi Song, Hui-mian Xu, Ying-ying Xu
      Journal of Surgical Research.2016; 203(2): 258.     CrossRef
    • Limited significance of curative surgery in Borrmann type IV gastric cancer
      Eun Young Kim, Han Mo Yoo, Kyo Young Song, Cho Hyun Park
      Medical Oncology.2016;[Epub]     CrossRef
    • An update on gastric cancer
      Syed A. Ahmad, Brent T. Xia, Christina E. Bailey, Daniel E. Abbott, Beth A. Helmink, Meghan C. Daly, Ramya Thota, Cameron Schlegal, Leah K. Winer, S. Ameen Ahmad, Ali H. Al Humaidi, Alexander A Parikh
      Current Problems in Surgery.2016; 53(10): 449.     CrossRef
    • CA125 is a potential biomarker to predict surgically incurable gastric and cardia cancer
      Taobo Luo, Wenhu Chen, Lifang Wang, Hongguang Zhao
      Medicine.2016; 95(51): e5297.     CrossRef
    • Undiagnosed Borrmann type IV gastric cancer despite repeated endoscopic biopsies and PET-CT examination: A case report
      Fang-Qing Zhu, Hong-Jin Chu, Zhao-Hua Gong, Feng-Cai Du, Jian Chen, Li-Xin Jiang
      Oncology Letters.2016; 12(2): 1485.     CrossRef
    • Variable Endoscopic Findings and Clinicopathological Characteristics of Borrmann Type 4 Advanced Gastric Cancer
      Ji Young Chang, Ki-Nam Shim, Chung Hyun Tae, A Reum Choe, Chang Mo Moon, Seong-Eun Kim, Hye-Kyung Jung, Sung-Ae Jung
      The Korean Journal of Helicobacter and Upper Gastrointestinal Research.2015; 15(3): 166.     CrossRef
    • Survival Benefit of Palliative Gastrectomy in Gastric Cancer Patients with Peritoneal Metastasis
      Masanori Tokunaga, Masanori Terashima, Yutaka Tanizawa, Etsuro Bando, Taiichi Kawamura, Hirofumi Yasui, Narikazu Boku
      World Journal of Surgery.2012; 36(11): 2637.     CrossRef
    • Risk Stratification for Serosal Invasion Using Preoperative Predictors in Patients with Advanced Gastric Cancer
      Sung-Sil Park, Jae-Seok Min, Kyu-Jae Lee, Sung-Ho Jin, Sunhoo Park, Ho-Yoon Bang, Hwang-Jong Yu, Jong-Inn Lee
      Journal of Gastric Cancer.2012; 12(3): 149.     CrossRef
    • An Insufficient Preoperative Diagnosis of Borrmann Type 4 Gastric Cancer in Spite of EMR
      Jae Bong Ahn, Tae Kyung Ha, Hang Rak Lee, Sung Joon Kwon
      Journal of Gastric Cancer.2011; 11(1): 59.     CrossRef
    • Gastric carcinoma: when is palliative gastrectomy justified?
      Hubert Scheidbach, Hans Lippert, Frank Meyer
      Oncology Reviews.2010; 4(2): 127.     CrossRef
    • Prognostic Factors in Gastric Cancer Patients with Peritoneal Carcinomatosis
      Hyun Il Kim, Tae Kyung Ha, Sung Joon Kwon
      Journal of Gastric Cancer.2010; 10(3): 126.     CrossRef
    • Prognosis of pN3 Stage Gastric Cancer
      Jung Ryun Ahn, Minkyu Jung, Chan Kim, Min Hee Hong, Hong Jae Chon, Hye Ryun Kim, Hei-Cheul Jeung, Woo Jin Hyung, Sung Sook Lee, Hyun Cheol Chung, Sung Hoon Noh, Sun Young Rha
      Cancer Research and Treatment.2009; 41(2): 73.     CrossRef
    • Borrmann Type IV: An Independent Prognostic Factor for Survival in Gastric Cancer
      Ji Yeong An, Tae Ho Kang, Min Gew Choi, Jae Hyung Noh, Tae Sung Sohn, Sung Kim
      Journal of Gastrointestinal Surgery.2008; 12(8): 1364.     CrossRef
    • Prognostic Factors for Advanced Gastric Cancer: Stage-stratified Analysis of Patients who Underwent Curative Resection
      Joong-Min Park, Woo-Sang Ryu, Jong-Han Kim, Sung-Soo Park, Seung-Joo Kim, Chong-Suk Kim, Young-Jae Mok
      Cancer Research and Treatment.2006; 38(1): 13.     CrossRef

    • PubReader PubReader
    • ePub LinkePub Link
    • Cite
      CITE
      export Copy Download
      Close
      Download Citation
      Download a citation file in RIS format that can be imported by all major citation management software, including EndNote, ProCite, RefWorks, and Reference Manager.
      Format:
      • RIS — For EndNote, ProCite, RefWorks, and most other reference management software
      • BibTeX — For JabRef, BibDesk, and other BibTeX-specific software
      Include:
      • Citation for the content below
      Clinicopathological Analysis of Borrmann Type IV Gastric Cancer
      Cancer Res Treat. 2005;37(2):87-91.   Published online April 30, 2005
      DOI: https://doi.org/10.4143/crt.2005.37.2.87
      Close
    • XML DownloadXML Download
    • 0
    • 1
    • 2
    • 3
    Clinicopathological Analysis of Borrmann Type IV Gastric Cancer
    Image Image Image Image
    Fig. 1 Age and sex distribution.
    Fig. 2 Comparison of survival rate between curative resection and other group (p<0.05).
    Fig. 3 Comparison of survival rate between resection and nonresection group in peritoneal seeding patients (p<0.05).
    Fig. 4 Comparison of effect to survival rate between negative and positive resection margin of gastrectomy in peritoneal seeding patients (p=0.84).

    Fig. 1

    Fig. 2

    Fig. 3

    Fig. 4

    Clinicopathological Analysis of Borrmann Type IV Gastric Cancer

    Clinical characteristics of Borrmann type IV gastric cancers (n=370)

    *(+) means positive microscopic cancer cell in tissue.

    Comparison of survival rates according to clinical factors in curative resection (n=182)

    *L=lower 1/3, M=middle 1/3, U=upper 1/3; †1 region=lower, middle, upper area, 2 regions=lower 1/3 + middle 1/3 or middle 1/3+ upper 1/3.

    Multivariate analysis of prognostic factors after curative resection (n=182)

    *Confidence interval.

    Site of recurrences after curative resection (n=121)
    Table 1 Clinical characteristics of Borrmann type IV gastric cancers (n=370)

    *(+) means positive microscopic cancer cell in tissue.

    Table 2 Comparison of survival rates according to clinical factors in curative resection (n=182)

    *L=lower 1/3, M=middle 1/3, U=upper 1/3; †1 region=lower, middle, upper area, 2 regions=lower 1/3 + middle 1/3 or middle 1/3+ upper 1/3.

    Table 3 Multivariate analysis of prognostic factors after curative resection (n=182)

    *Confidence interval.

    Table 4 Site of recurrences after curative resection (n=121)

    Table 1

    Table 2

    Table 3

    Table 4

    Cancer Res Treat : Cancer Research and Treatment
    © Korean Cancer Association.
    Close layer
    TOP